Gilad Oren has filed 19 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 20175 shares of Aprea Therapeutics, Inc. ($APRE) on March 12, 2026.
Activity breakdown: 13 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | A | Common Stock | 20175 | $0.00 | 395,695.0000 | 6,372,938 | 5.37% | 0.32% |
| March 12, 2026 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | A | Stock Options (Right to Buy) | 80700 | $0.00 | 80,700.0000 | 6,372,938 | 9999.99% | 1.27% |
| Jan. 30, 2026 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Warrant | 28100 | $0.00 | 28,100.0000 | 6,372,938 | 9999.99% | 0.44% |
| Jan. 30, 2026 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Stock | 28100 | $0.89 | 375,520.0000 | 6,372,938 | 8.09% | 0.44% |
| Dec. 10, 2025 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Warrants | 21459 | $0.00 | 21,459.0000 | 6,372,938 | 9999.99% | 0.34% |
| Dec. 10, 2025 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Pre-Funded Warrant | 21459 | $1.17 | 21,459.0000 | 6,372,938 | 9999.99% | 0.34% |
| April 3, 2025 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Stock | 2497 | $1.80 | 347,420.0000 | 5,993,866 | 0.72% | 0.04% |
| April 3, 2025 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Stock | 3003 | $1.87 | 344,923.0000 | 5,993,866 | 0.88% | 0.05% |
| March 27, 2025 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | A | Common Stock | 6725 | $0.00 | 341,920.0000 | 5,509,921 | 2.01% | 0.12% |
| March 27, 2025 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | A | Stock Options (Right to Buy) | 26900 | $0.00 | 26,900.0000 | 5,509,921 | 9999.99% | 0.49% |
| Oct. 23, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Stock | 500 | $3.92 | 335,195.0000 | 5,939,755 | 0.15% | 0.01% |
| Oct. 15, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Stock | 250 | $2.90 | 334,695.0000 | 5,939,755 | 0.07% | 0.00% |
| Oct. 10, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Stock | 150 | $2.54 | 333,445.0000 | 5,939,755 | 0.05% | 0.00% |
| Oct. 14, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President/CEO | P | Common Stock | 1000 | $2.59 | 334,445.0000 | 5,939,755 | 0.30% | 0.02% |
| March 28, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President, CEO | A | Common Stock | 6725 | $0.00 | 333,295.0000 | 3,617,607 | 2.06% | 0.19% |
| March 28, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President, CEO | A | Stock Options (Right to Buy) | 26900 | $0.00 | 26,900.0000 | 3,617,607 | 9999.99% | 0.74% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President, CEO | P | Tranche B Warrant | 1000 | $0.00 | 1,000.0000 | 3,617,607 | 9999.99% | 0.03% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President, CEO | P | Tranche A Warrant | 1000 | $0.00 | 1,000.0000 | 3,617,607 | 9999.99% | 0.03% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | Gilad Oren | President, CEO | P | Common Stock | 2000 | $7.29 | 324,770.0000 | 3,617,607 | 0.62% | 0.06% |